Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jun 1;23(11):2655-2664.
doi: 10.1158/1078-0432.CCR-16-2630.

Breast Cancer Disparities at Home and Abroad: A Review of the Challenges and Opportunities for System-Level Change

Katherine E Reeder-Hayes  1   2 , Benjamin O Anderson  3   4
Affiliations
Editorial

Breast Cancer Disparities at Home and Abroad: A Review of the Challenges and Opportunities for System-Level Change

Katherine E Reeder-Hayes et al. Clin Cancer Res. .

Abstract

Sizeable disparities exist in breast cancer outcomes, both between Black and White patients in the United States, and between patients in the United States and other high-income countries compared with low- and middle-income countries (LMIC). In both settings, health system factors are key drivers of disparities. In the United States, Black women are more likely to die of breast cancer than Whites and have poorer outcomes, even among patients with similar stage and tumor subtype. Over-representation of higher risk "triple-negative" breast cancers contributes to breast cancer mortality in Black women; however, the greatest survival disparities occur within the good-prognosis hormone receptor-positive (HR+) subtypes. Disparities in access to treatment within the complex U.S. health system may be responsible for a substantial portion of these differences in survival. In LMICs, breast cancer mortality rates are substantially higher than in the United States, whereas incidence continues to rise. This mortality burden is largely attributable to health system factors, including late-stage presentation at diagnosis and lack of availability of systemic therapy. This article will review the existing evidence for how health system factors in the United States contribute to breast cancer disparities, discuss methods for studying the relationship of health system factors to racial disparities, and provide examples of health system interventions that show promise for mitigating breast cancer disparities. We will then review evidence of global breast cancer disparities in LMICs, the treatment factors that contribute to these disparities, and actions being taken to combat breast cancer disparities around the world. Clin Cancer Res; 23(11); 2655-64. ©2017 AACRSee all articles in this CCR Focus section, "Breast Cancer Research: From Base Pairs to Populations."

PubMed Disclaimer

Conflict of interest statement

Dr. Reeder-Hayes has no conflicts of interest to disclose.

Dr. Anderson has no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
a: Trends in age-adjusted incidence and mortality of breast cancer in US black and white women, 1975–2013 (data from Surveillance Epidemiology and End Results (SEER) 9 Sites) b: Trends in Age-Standardized Breast Cancer Incidence, Selected Countries, 1975–2010. Source: Ferlay and others 2013; WHO Mortality Database (http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html), previously published.(107) c: Trends in Age-Standardized Breast Cancer Mortality, Selected Countries, 1975–2010. Source: Ferlay and others 2013; WHO Mortality Database (http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html), previously published.(107)
Figure 1
Figure 1
a: Trends in age-adjusted incidence and mortality of breast cancer in US black and white women, 1975–2013 (data from Surveillance Epidemiology and End Results (SEER) 9 Sites) b: Trends in Age-Standardized Breast Cancer Incidence, Selected Countries, 1975–2010. Source: Ferlay and others 2013; WHO Mortality Database (http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html), previously published.(107) c: Trends in Age-Standardized Breast Cancer Mortality, Selected Countries, 1975–2010. Source: Ferlay and others 2013; WHO Mortality Database (http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html), previously published.(107)
Figure 1
Figure 1
a: Trends in age-adjusted incidence and mortality of breast cancer in US black and white women, 1975–2013 (data from Surveillance Epidemiology and End Results (SEER) 9 Sites) b: Trends in Age-Standardized Breast Cancer Incidence, Selected Countries, 1975–2010. Source: Ferlay and others 2013; WHO Mortality Database (http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html), previously published.(107) c: Trends in Age-Standardized Breast Cancer Mortality, Selected Countries, 1975–2010. Source: Ferlay and others 2013; WHO Mortality Database (http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html), previously published.(107)
Figure 2
Figure 2
Contributors to US and global outcome disparities in breast cancer across the cancer care continuum. In addition to lack of any treatment (e.g. lack of radiation, lack of chemotherapy), specific treatment gaps are listed in each bar.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. 2014;106(5) doi: 10.1093/jnci/dju055. - DOI - PMC - PubMed
    1. DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA: a cancer journal for clinicians. 2016;66(1):31–42. doi: 10.3322/caac.21320. - DOI - PubMed
    1. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492–502. doi: 10.1001/jama.295.21.2492. doi 295/21/2492 [pii] - DOI - PubMed
    1. Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1994;3(2):127–35. - PubMed
    1. Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, et al. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer. 2004;100(12):2533–42. doi: 10.1002/cncr.20279. - DOI - PubMed

Publication types